Verastem (FRA:2VSA) Ending Cash Position : €85.05 Mil (As of Dec. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Verastem Ending Cash Position?

Verastem's Ending Cash Position for the quarter that ended in Dec. 2024 was €85.05 Mil.

Verastem's quarterly Ending Cash Position increased from Jun. 2024 (€77.68 Mil) to Sep. 2024 (€102.19 Mil) but then declined from Sep. 2024 (€102.19 Mil) to Dec. 2024 (€85.05 Mil).

Verastem's annual Ending Cash Position increased from Dec. 2022 (€71.55 Mil) to Dec. 2023 (€72.51 Mil) and increased from Dec. 2023 (€72.51 Mil) to Dec. 2024 (€85.05 Mil).

Verastem Ending Cash Position Historical Data

The historical data trend for Verastem's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verastem Ending Cash Position Chart

Verastem Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

55.92

19.02

71.55

72.51

85.05

Verastem Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															72.51	75.99	77.68	102.19	85.05

Verastem Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Verastem's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	75.517	+	9.534
	=	85.05

Verastem's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	108.312	+	-23.261
	=	85.05

Verastem Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Verastem's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Verastem Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verastem Inc (FRA:2VSA) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

VSTM:USA 0LOV:UK 2VS:Germany

Address

117 Kendrick Street, Suite 500, Needham, MA, USA, 02494

Website

https://www.verastem.com

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Verastem Headlines

No Headlines